Mainboard · BSE and NSEDraft filed

VARDAAN BIOTECH LIMITED IPO: dates, price band, lot size, objects of the issue

Get updates on this IPO

Dates, price band, allotment and listing notices by email, and new views from SEBI-registered research analysts on InsightPier by email.

Dates, allotment, listing and analyst views. Stop anytime.

By continuing you agree to the Terms and Privacy policy

Updated Sun 15 Nov 2026, 8:04 pm IST · Source: DRHP dated Fri 18 Sep 2026

Key facts

Price band
Not announced
Lot size
Not announced
Lot amount at the upper band
Not announced
Issue size at the upper band
3,50,00,000 shares (Amount not stated in the draft)
DRHP dated Fri 18 Sep 2026, page 1
Fresh issue
3,50,00,000 shares (Amount not stated in the draft)
DRHP dated Fri 18 Sep 2026, page 1
Offer for sale
None
DRHP dated Fri 18 Sep 2026, page 1
Bid dates
Not announced
Listing date
Not announced
Risk factors
Not announced
Proposed exchanges
BSE and NSE

Timeline (IST)

  1. Draft filedTue 22 Sep 2026 confirmedDRHP dated Fri 18 Sep 2026
  2. OpensDates to be announced
  3. ClosesDates to be announced
  4. AllotmentDates to be announced
  5. Refund and unblockDates to be announced
  6. ListingDates to be announced

Company and promoters

As described in the DRHP

We are an integrated seed company engaged in the development, breeding, production, processing, conditioning, of agricultural seeds across multiple crop varieties.

DRHP dated Fri 18 Sep 2026, page 179

Promoters

  • 2 individual promoters

DRHP dated Fri 18 Sep 2026, page 240

Shareholding

HoldingBefore the issueAfter the issue
Promoters and promoter group71.96%Not stated in the DRHP

DRHP dated Fri 18 Sep 2026, page 93

Financials (restated)

ItemMarch 31, 2026March 31, 2025March 31, 2024
Revenue from operations₹167.09 crore₹151.13 crore₹140.14 crore
Profit after tax₹18.35 crore₹17.61 crore₹16.48 crore
Net worth₹99.55 crore₹61.00 crore₹43.37 crore
Total borrowingsNot stated in the draftNot stated in the draftNot stated in the draft

DRHP dated Fri 18 Sep 2026, page 67

Peer comparison (as in the DRHP)

CompaniesCMP (₹)EPS (₹)PE RationRONW (%)NAV (Per Share) (₹)Face Value (₹)Revenue from Operation (₹ in Lakhs)Other Income (₹ in Lakhs)Total Income (₹ in Lakhs)
Vardaan Biotech Limited[●]12.53[●]18.4356.771016,709.3718.8216,728.19
Nath Bio-Genes (India) Ltd153.9320.987.996.12385.0610.0044,510.15781.0045,291.15
Indo US Bio-Tech Ltd85.966.5414.2114.1846.1510.0011,043.915.4211,049.33
Bombay Super Hybrid Seeds Ltd88.072.5433.2020.3512.491.0034,408.4487.634,496.04
Kaveri Seed Company Limited773.4056.9415.4416.86341.062.001,39,476.262930.331,42,406.59

Reproduced from the DRHP dated Fri 18 Sep 2026, page 121; InsightPier adds no figures

Risk factors

  1. A promoter faces a pending criminal case and investigation by the Economic Offences Wing (DRHP page 27)
  2. Weather, crop disease and pests can hurt operations and finances (DRHP page 27)
  3. Revenue depends heavily on a few seed products, mainly maize, paddy and wheat seeds (DRHP page 28)
  4. Procurement is concentrated in Telangana, Madhya Pradesh and Gujarat (DRHP page 29)
  5. Revenue is concentrated in a few states, mainly Madhya Pradesh and Maharashtra (DRHP page 30)

Offer document

Research

Research reports on IPOs from SEBI-registered research analysts, published on InsightPier.

Research reports on IPOs from SEBI-registered research analysts